Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Parasites & Vectors
|
July 24, 2025
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study
Nicholas O Opoku, Felix Doe, Mannel E Agbogah, et al.
Epidemiology and Infection
|
February 16, 2018
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics
D B C Wu, N Chaiyakunapruk, C Pratoomsoot, et al.
British Journal of Clinical Pharmacology
|
February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics
Mohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Lancet Regional Health. Americas
|
December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Lancet Regional Health. Americas
|
November 12, 2025
Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142]
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silv, Daniela Carla Medeiros Silv, et al.
The New England Journal of Medicine
|
March 30, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Gilmar Reis, Eduardo A S M Silva, Daniela C M Silva, et al.
The Lancet. Global Health
|
October 31, 2021
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, et al.
Annals of Internal Medicine
|
April 17, 2023
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
The New England Journal of Medicine
|
February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19
Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Parasites & Vectors
|
July 24, 2025
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study
Nicholas O Opoku, Felix Doe, Mannel E Agbogah, et al.
Epidemiology and Infection
|
February 16, 2018
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics
D B C Wu, N Chaiyakunapruk, C Pratoomsoot, et al.
British Journal of Clinical Pharmacology
|
February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics
Mohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Lancet Regional Health. Americas
|
December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Lancet Regional Health. Americas
|
November 12, 2025
Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142]
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silv, Daniela Carla Medeiros Silv, et al.
The New England Journal of Medicine
|
March 30, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Gilmar Reis, Eduardo A S M Silva, Daniela C M Silva, et al.
The Lancet. Global Health
|
October 31, 2021
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, et al.
Annals of Internal Medicine
|
April 17, 2023
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial
Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
The New England Journal of Medicine
|
February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19
Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Page
of 15